Respiratory Drug Delivery Formulation Market Expansion Projected To Gain An Uptick During 2026


Respiratory drug delivery formulations are used for treating various respiratory diseases. The pulmonary route of drug delivery is most effective in recent times for treatment of respiratory diseases as it enables to target drug delivery directly to lung both for local and systemic treatment. There are various types of drug delivery in respiratory system like inhalers, capsules. The formulations can also be delivered by the oral or nasal route. Respiratory drug delivery formulations market are categorized as solution aerosol, suspension aerosol and dry powder. Metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers are used for successful delivery of a wide range of pharmaceutical drugs to the lungs. Respiratory drug delivery formulations are largely used to treat chronic obstructive pulmonary disease, asthma, and cystic fibrosis.

As per the Global Asthma Network, 2014, asthma affects nearly 334 million people worldwide, thus increase in prevalence and incidence of respiratory diseases has led to increase in demand for the respiratory drug delivery formulations market. Pharmaceutical manufacturers are focused on increasing access to affordable medications to provide novel options to patients and pharmacists, thereby addressing the limited availability of respiratory drug delivery formulations, which in turn is expected to augment market growth. For instance, in August, 2017, Teva Pharmaceuticals announced that the U.S. FDA approved its QVAR RediHaler inhalation aerosol used for the maintenance treatment of asthma as a prophylactic therapy in patients aged 4 years and older. Furthermore, in December 2018, Teva Pharmaceuticals received U.S. FDA approval for its ProAir Digihaler device, a digital inhaler that uses sensors to connect to mobile app. It is indicated for the treatment of bronchospasm in people with reversible obstructive airway disease.

Moreover, rising prevalence of various infectious diseases, including respiratory tract infections, is expected to drive growth of the respiratory drug delivery formulation market in the near future. For instance, according to a study published in the Lancet Global Health Journal, in 2016, an estimated 55.3 million cases of chronic obstructive pulmonary disease were observed in India.

Respiratory drug delivery formulation Market- Competitive Analysis
Manufacturers are focused on development, manufacturing, and marketing of multisource and branded pharmaceuticals, thereby augmenting the market growth. For instance, in November 2017, AstraZeneca announced that the U.S. Food and Drug Administration (FDA) approved Fasenra (benralizumab) for the treatment of patients with severe asthma, aged 12 years and older.

Key players operating in the global respiratory drug delivery formulation market include Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, 3M, AstraZeneca plc, Merck and Co., Inc., Omron Corporation, Novartis AG, Boehringer Ingelheim GmbH, Sunovion Pharmaceuticals Inc., Hovione, Catalent Pharma Solutions, and Aphios Corporation.

Comments

Post a Comment

Popular posts from this blog

U.S. Meibomian Gland Dysfunction Market is growing rapidly with ThermaMEDx introducing a self-healing, disposable, pre-moistened, sterile cleaning eye-pad for use in treating the symptoms of dry eyes and meibomian gland dysfunction

Image
Dysfunction of any of these three glands can result in Meibomian gland dysfunction. A primary cause for this condition is not really the disease itself but rather the abnormal overproduction of sebum (the secreted liquid of glands). This is normally controlled by the hypothalamus-pituitary gland system which inhibits the secretion of oil. Rapidly increases the prevalence of meibomian gland dysfunction remains one of the critical factors aiding the development of the market. In fact, as per the Fellow of American College of Surgeons, meibomian gland disease, is one of the most common causes of dry eyes and around 50-70% of the elderly population has some degree of dry eye. Besides, as per the American Optometric Association’s study in 2017, over 16 million people in the U.S. were suffering from dry eye disease. Such factors can indeed stimulate growth of the U.S. meibomian gland dysfunction market. When it comes to the drug type, Cyclosporine segment seems to be exhibiting positive trac...
Read more

Boston Sci Launched A New Device For Erectile Dysfunction Devices Market

Image
  North America is expected to hold the major share in the global erectile dysfunction devices market and this is attributed to the continuous innovation in the device by key players in the region. For instance, in July 2019, Boston Scientific announced the launch of the Tactra penile implant, which is a durable implant with a natural feel for treating ED. Also, in August 2019, Ohio, U.S.-based Integrated Medical announced that they are offering a state-of-the-art Extra Corporeal Shock Wave Therapy (ESWT) for treating ED. The therapy will utilize power generated through acoustic sound waves and radial shockwaves to stimulate neovascularization The growing prevalence of cardiovascular or diabetes disease among men undergoing such treatment are at higher risk of developing erectile dysfunction. This is driving the growth of the  erectile dysfunction devices market . Vacuum pumps, also known as Vacuum Erection devices (VED) are gaining huge demand around the globe. According to t...
Read more

Bakeable Trays Market Estimated To Develop At Cagr at 4.8% During Estimate Duration 2019-2027

Image
The expansion of direct bundle to-broiler pastry shop items have pushed the market for bakeable trays. While these items have been around for some time, the rise of new sorts of bakeable trays features the market's development as of late. Contrasted with the conventional preparing trays which are comprised of metal, the bakeable trays are produced using a ridged paper card board that is both warmth safe and water confirmation. Such trays are made to withstand temperatures up to 220°C. These bakeable or ovenable trays are offered in various sizes and shapes. Bakeable trays can even be tweaked for various end use applications. One of the differentiating highlights of bakeable trays is that they are made of bio-degradable substance and are recyclable. These are likewise endorsed by different food organizations for direct food contact making it more secure to buyer straightforwardly from them. The worldwide  bakeable trays market  is required to arrive at US$ 1,943.8 million by 20...
Read more